概括
支持性住房为痴呆症患者提供了创新的解决方案,超越了传统的护理选择. 这种方法通过解决未满足的住房需求来增强自主性和社会参与.
科学领域:
- 老年学是一门学科.
- 住房研究 住房研究
- 痴呆症护理研究研究
背景情况:
- 传统的痴呆症护理往往在现场老龄化和制度化之间存在分歧.
- 现有的住房模式可能无法充分满足痴呆症患者不断变化的需求.
- 需要采用综合方法来支持自主和社会参与.
研究的目的:
- 探索支持性住房原则如何满足痴呆症患者未解决的住房需求.
- 促进痴呆症护理和支持性住房部门之间的对话.
- 确定新的住房解决方案,以促进痴呆症患者的代理,自主和社会参与.
主要方法:
- 对来自支持性住房的记录和事策略的分析.
- 从心理健康,行为健康和痴呆症护理中整合跨学科的见解.
- 检查支持性住房的核心价值观,指导原则和实践.
主要成果:
- 支持性住房框架可以调整以满足痴呆症患者的特定需求.
- 跨学科的方法揭示了增强代理和自主性的潜力.
- 新型住房选择可以促进持续的社会参与,超越传统的护理环境.
结论:
- 支持性住房为传统痴呆症护理机构提供了一个有希望的替代方案.
- 整合支持性住房原则可以显著改善痴呆症患者的生活质量.
- 进一步研究和实施这些住房模型是有必要的.
相关概念视频
Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Continuing Care
1.9K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Cognitive Development During Adulthood
783
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
783
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


